Table 1 Daily dosage (mg) for each intervention with breakdown of components.

From: A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome

Intervention

Primary Components

Daily Dosage (mg)

Ganoderma lucidum

Ganoderma lucidum mushroom extract (10:1)

2,240

Ganoderma lucidum spores

740

Excipient

700

Total

3,680

Ganoderma lucidum with Cordyceps sinensis

Ganoderma lucidum mushroom extract (10:1)

2,250

Ganoderma lucidum spores

750

Cordyceps sinensis mushroom extract

1,000

Excipient

130

Total

4,120

Placebo

Excipient

3,630